Thomas Rolland

Thomas Rolland

Auto-generated profile, based on publicly available information

Thomas Rolland

Institut Pasteur

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Cell
Verified
Journal Article
Closed access
TRThomas Rolland
Thomas Rolland
MTMurat Taşan
Murat Taşan
BCBenoit Charloteaux
Benoit Charloteaux
SPSamuel J. Pevzner
Samuel J. Pevzner
QZQuan Zhong
Quan Zhong
MVMarc Vidal
Marc Vidal

24 June 2012 in Nature
Verified
Journal Article
Open access
PDF file
ACAnne-Ruxandra Carvunis
Anne-Ruxandra Carvunis
TRThomas Rolland
Thomas Rolland
IWIlan Wapinski
Ilan Wapinski
MCMichael A. Calderwood
Michael A. Calderwood
MYMuhammed A. Yildirim
Muhammed A. Yildirim
MVMarc Vidal
Marc Vidal
Novel protein-coding genes can arise either from pre-existing genes or de novo; here it is shown that functional genes emerge de novo through transitory proto-genes generated by widespread translational activity in non-genic sequences. De novo gene birth has occurred in many lineages during evolution, but how functional protein-coding genes emerge in non-functional sequences — rather than through gene rearrangement — remains unresolved. These authors observe in the yeast Saccharomyces cerevisiae that hundreds of species-specific non-genic transcripts are differentially regulated upon stress. These previously overlooked translation events seem to act as a reservoir of adaptive potential, in the form of open reading frames that occupy an evolutionary continuum ranging from non-genic sequences to genes. On the basis of their genome-wide observations, the authors suggest that de novo gene birth from the proto-gene reservoir may be more prevalent than sporadic gene duplication. Novel protein-coding genes can arise either through re-organization of pre-existing genes or de novo1,2. Processes involving re-organization of pre-existing genes, notably after gene duplication, have been extensively described1,2. In contrast, de novo gene birth remains poorly understood, mainly because translation of sequences devoid of genes, or ‘non-genic’ sequences, is expected to produce insignificant polypeptides rather than proteins with specific biological functions1,3,4,5,6. Here we formalize an evolutionary model according to which functional genes evolve de novo through transitory proto-genes4 generated by widespread translational activity in non-genic sequences. Testing this model at the genome scale in Saccharomyces cerevisiae, we detect translation of hundreds of short species-specific open reading frames (ORFs) located in non-genic sequences. These translation events seem to provide adaptive potential7, as suggested by their differential regulation upon stress and by signatures of retention by natural selection. In line with our model, we establish that S. cerevisiae ORFs can be placed within an evolutionary continuum ranging from non-genic sequences to genes. We identify ∼1,900 candidate proto-genes among S. cerevisiae ORFs and find that de novo gene birth from such a reservoir may be more prevalent than sporadic gene duplication. Our work illustrates that evolution exploits seemingly dispensable sequences to generate adaptive functional innovation.

1 November 2014 in Cell Reports
Verified
Journal Article
Open access
Marc BrehmeMarc Brehme
Marc Brehme
CVCindy Voisine
Cindy Voisine
TRThomas Rolland
Thomas Rolland
SWShinichiro Wachi
Shinichiro Wachi
JSJames H. Soper
James H. Soper
RMRichard I. Morimoto
Richard I. Morimoto
Chaperones are central to the proteostasis network (PN) and safeguard the proteome from misfolding, aggregation, and proteotoxicity. We categorized the human chaperome of 332 genes into network communities using function, localization, interactome, and expression data sets. During human brain aging, expression of 32% of the chaperome, corresponding to ATP-dependent chaperone machines, is repressed, whereas 19.5%, corresponding to ATP-independent chaperones and co-chaperones, are induced. These repression and induction clusters are enhanced in the brains of those with Alzheimer's, Huntington's, or Parkinson's disease. Functional properties of the chaperome were assessed by perturbation in C. elegans and human cell models expressing Aβ, polyglutamine, and Huntingtin. Of 219 C. elegans orthologs, knockdown of 16 enhanced both Aβ and polyQ-associated toxicity. These correspond to 28 human orthologs, of which 52% and 41% are repressed, respectively, in brain aging and disease and 37.5% affected Huntingtin aggregation in human cells. These results identify a critical chaperome subnetwork that functions in aging and disease.

18 July 2012 in Nature
Verified
Journal Article
Open access
PDF file
OROrit Rozenblatt-Rosen
Orit Rozenblatt-Rosen
RDRahul C. Deo
Rahul C. Deo
MPMegha Padi
Megha Padi
GAGuillaume Adelmant
Guillaume Adelmant
MCMichael A. Calderwood
Michael A. Calderwood
MVMarc Vidal
Marc Vidal
Combining analysis of host proteome and transcriptome perturbations induced by tumour virus proteins with ongoing genome-wide studies of cancer facilitates the prioritization of cancer genes. This systematic search for host targets of tumour viruses, using proteome and transcriptome analyses of viral proteins from mammalian DNA viruses with transforming or tumorigenic properties, provides an extensive catalogue of changes in genetic and protein expression that can be screened against genome-wide studies of cancer. The study focuses on human papillomavirus, Epstein–Barr virus, adenovirus and polyomavirus. The resulting list of transforming viral protein targets identifies causal genes within both somatic and Mendelian cancer-associated loci. Genotypic differences greatly influence susceptibility and resistance to disease. Understanding genotype–phenotype relationships requires that phenotypes be viewed as manifestations of network properties, rather than simply as the result of individual genomic variations1. Genome sequencing efforts have identified numerous germline mutations, and large numbers of somatic genomic alterations, associated with a predisposition to cancer2. However, it remains difficult to distinguish background, or ‘passenger’, cancer mutations from causal, or ‘driver’, mutations in these data sets. Human viruses intrinsically depend on their host cell during the course of infection and can elicit pathological phenotypes similar to those arising from mutations3. Here we test the hypothesis that genomic variations and tumour viruses may cause cancer through related mechanisms, by systematically examining host interactome and transcriptome network perturbations caused by DNA tumour virus proteins. The resulting integrated viral perturbation data reflects rewiring of the host cell networks, and highlights pathways, such as Notch signalling and apoptosis, that go awry in cancer. We show that systematic analyses of host targets of viral proteins can identify cancer genes with a success rate on a par with their identification through functional genomics and large-scale cataloguing of tumour mutations. Together, these complementary approaches increase the specificity of cancer gene identification. Combining systems-level studies of pathogen-encoded gene products with genomic approaches will facilitate the prioritization of cancer-causing driver genes to advance the understanding of the genetic basis of human cancer.

12 June 2009 in Genome Research
Verified
Journal Article
Closed access
PDF file
TCThe Génolevures Consortium
The Génolevures Consortium
JSJean-Luc Souciet
Jean-Luc Souciet
BDBernard Dujon
Bernard Dujon
CGClaude Gaillardin
Claude Gaillardin
MJMark Johnston
Mark Johnston
ETEmmanuel Talla
Emmanuel Talla
Our knowledge of yeast genomes remains largely dominated by the extensive studies on Saccharomyces cerevisiae and the consequences of its ancestral duplication, leaving the evolution of the entire class of hemiascomycetes only partly explored. We concentrate here on five species of Saccharomycetaceae, a large subdivision of hemiascomycetes, that we call “protoploid” because they diverged from the S. cerevisiae lineage prior to its genome duplication. We determined the complete genome sequences of three of these species: Kluyveromyces (Lachancea) thermotolerans and Saccharomyces (Lachancea) kluyveri (two members of the newly described Lachancea clade), and Zygosaccharomyces rouxii. We included in our comparisons the previously available sequences of Kluyveromyces lactis and Ashbya (Eremothecium) gossypii. Despite their broad evolutionary range and significant individual variations in each lineage, the five protoploid Saccharomycetaceae share a core repertoire of approximately 3300 protein families and a high degree of conserved synteny. Synteny blocks were used to define gene orthology and to infer ancestors. Far from representing minimal genomes without redundancy, the five protoploid yeasts contain numerous copies of paralogous genes, either dispersed or in tandem arrays, that, altogether, constitute a third of each genome. Ancient, conserved paralogs as well as novel, lineage-specific paralogs were identified.

1 September 2014 in Genes & Development
Verified
Journal Article
Open access
PDF file
SHSarah J. Hill
Sarah J. Hill
TRThomas Rolland
Thomas Rolland
GAGuillaume Adelmant
Guillaume Adelmant
XXXianfang Xia
Xianfang Xia
MOMatthew S. Owen
Matthew S. Owen
DLDavid M. Livingston
David M. Livingston
BRCA1 is a breast and ovarian tumor suppressor. Given its numerous incompletely understood functions and the possibility that more exist, we performed complementary systematic screens in search of new BRCA1 protein-interacting partners. New BRCA1 functions and/or a better understanding of existing ones were sought. Among the new interacting proteins identified, genetic interactions were detected between BRCA1 and four of the interactors: TONSL, SETX, TCEANC, and TCEA2. Genetic interactions were also detected between BRCA1 and certain interactors of TONSL, including both members of the FACT complex. From these results, a new BRCA1 function in the response to transcription-associated DNA damage was detected. Specifically, new roles for BRCA1 in the restart of transcription after UV damage and in preventing or repairing damage caused by stabilized R loops were identified. These roles are likely carried out together with some of the newly identified interactors. This new function may be important in BRCA1 tumor suppression, since the expression of several interactors, including some of the above-noted transcription proteins, is repeatedly aberrant in both breast and ovarian cancers.